354 related articles for article (PubMed ID: 21399867)
1. Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin.
Zhao S; Ye G; Fu G; Cheng JX; Yang BB; Peng C
Int J Oncol; 2011 May; 38(5):1319-27. PubMed ID: 21399867
[TBL] [Abstract][Full Text] [Related]
2. Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3.
Hsieh TC; Wu JM
Int J Mol Med; 2011 Dec; 28(6):1065-9. PubMed ID: 21887458
[TBL] [Abstract][Full Text] [Related]
3. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3.
Jiang J; Slivova V; Valachovicova T; Harvey K; Sliva D
Int J Oncol; 2004 May; 24(5):1093-9. PubMed ID: 15067330
[TBL] [Abstract][Full Text] [Related]
4. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling.
Jiang J; Slivova V; Harvey K; Valachovicova T; Sliva D
Nutr Cancer; 2004; 49(2):209-16. PubMed ID: 15489214
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
[TBL] [Abstract][Full Text] [Related]
6. Ganoderma lucidum induced apoptosis in NB4 human leukemia cells: involvement of Akt and Erk.
Calviño E; Manjón JL; Sancho P; Tejedor MC; Herráez A; Diez JC
J Ethnopharmacol; 2010 Mar; 128(1):71-8. PubMed ID: 20036724
[TBL] [Abstract][Full Text] [Related]
7. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
8. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Ganoderma lucidum spores on HepG2 cells proliferation and growth cycle].
Li L; Li T; Wang XJ; Xu JP; Wang SG
Zhong Yao Cai; 2008 Oct; 31(10):1514-8. PubMed ID: 19230404
[TBL] [Abstract][Full Text] [Related]
10. Anticancer properties of Ganoderma lucidum methanol extracts in vitro and in vivo.
Harhaji Trajković LM; Mijatović SA; Maksimović-Ivanić DD; Stojanović ID; Momcilović MB; Tufegdzić SJ; Maksimović VM; Marjanović ZS; Stosić-Grujicić SD
Nutr Cancer; 2009; 61(5):696-707. PubMed ID: 19838944
[TBL] [Abstract][Full Text] [Related]
11. Ganoderma lucidum (Reishi) in cancer treatment.
Sliva D
Integr Cancer Ther; 2003 Dec; 2(4):358-64. PubMed ID: 14713328
[TBL] [Abstract][Full Text] [Related]
12. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells.
Tang W; Liu JW; Zhao WM; Wei DZ; Zhong JJ
Life Sci; 2006 Dec; 80(3):205-11. PubMed ID: 17007887
[TBL] [Abstract][Full Text] [Related]
13. Strong cytotoxic effect of the bradykinin antagonist BKM-570 in ovarian cancer cells--analysis of the molecular mechanisms of its antiproliferative action.
Jutras S; Bachvarova M; Keita M; Bascands JL; Mes-Masson AM; Stewart JM; Gera L; Bachvarov D
FEBS J; 2010 Dec; 277(24):5146-60. PubMed ID: 21078129
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
Qamar L; Davis R; Anwar A; Behbakht K
Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
[TBL] [Abstract][Full Text] [Related]
15. Effects of mifepristone on the proliferation, apoptosis and cis-diamminedichloroplatinum sensitivity of cultured chemoresistant human ovarian cancer cells.
Wang G; Shang HL; Xie Y; Xiao P; Li XJ; Lin TC; Li GY
Chin Med J (Engl); 2005 Feb; 118(4):333-6. PubMed ID: 15740674
[No Abstract] [Full Text] [Related]
16. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.
Yang X; Fraser M; Moll UM; Basak A; Tsang BK
Cancer Res; 2006 Mar; 66(6):3126-36. PubMed ID: 16540663
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
18. AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate.
Shaw TJ; Vanderhyden BC
Gynecol Oncol; 2007 Apr; 105(1):122-31. PubMed ID: 17169414
[TBL] [Abstract][Full Text] [Related]
19. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
Xie XK; Yang DS; Ye ZM; Tao HM
Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of radiation response with combined Ganoderma lucidum and Duchesnea chrysantha extracts in human leukemia HL-60 cells.
Kim KC; Jun HJ; Kim JS; Kim IG
Int J Mol Med; 2008 Apr; 21(4):489-98. PubMed ID: 18360695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
